Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Chemistry

Epidemiology

Immunology

Show all topics

DOI

10.1101/2023.04.03.535447

License

CC-BY

Other Formats

PDF